Purification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomes.
Rats are a common animal model for metabolism and toxicity studies. Previously, the enzymatic properties of rat flavin-containing monooxygenase (FMO) 1 purified from hepatic and renal microsomes and that of FMO3 purified from hepatic microsomes were characterized. This study investigated the physical, immunological, and enzymatic properties of FMO3 purified from male rat kidney microsomes and compared the results with those obtained with isolated rat liver FMO3. Renal FMO3 was purified via affinity columns based on the elution of L-methionine (Met) S-oxidase activity and reactivity of the eluted proteins with human FMO3 antibody. In general, Met S-oxidase-specific activity was increased 100-fold through the purification steps. The resulting protein had similar mobility (approximately 56 kDa) as isolated rat liver FMO3 and cDNA-expressed human FMO3 by SDS-polyacrylamide gel electrophoresis. When the isolated kidney protein band was subjected to trypsin digestion and matrix-assisted laser desorption ionization/time of flight mass spectral analysis, 34% of the sequence of rat FMO3 was detected. The apparent K(m) and V(max) values for rat kidney FMO3 were determined using the known FMO substrates Met, seleno-L-methionine, S-allyl-L-cysteine (SAC), and methimazole (N-methyl-2-mercaptoimidazole). The stereoselectivity of the reactions with Met and SAC were also examined using high-performance liquid chromatography. The obtained kinetic and stereoselectivity results were similar to those we obtained in the present study, or those previously reported, for rat liver FMO3. Taken together, the results demonstrate many similar properties between rat hepatic and renal FMO3 forms and suggest that renal FMO3 may play an important role in kidney metabolism of xenobiotics containing sulfur and selenium atoms.
Novick
Rachel M
RM
Department of Comparative Biosciences and Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin 53706, USA.
Elfarra
Adnan A
AA
D000595:Amino Acid Sequence; D000818:Animals; D002384:Catalysis; D003545:Cysteine / Q000031:analogs & derivatives / Q000737:chemistry; D007668:Kidney / Q000737:chemistry*; D007700:Kinetics; D008297:Male; D008713:Methimazole / Q000737:chemistry; D008715:Methionine / Q000737:chemistry / Q000378:metabolism; D008861:Microsomes / Q000737:chemistry*; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009249:NADP / Q000737:chemistry; D010105:Oxygenases / Q000737:chemistry* / Q000302:isolation & purification*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012645:Selenomethionine / Q000737:chemistry; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013237:Stereoisomerism
D009249:NADP; D008713:Methimazole; C065299:S-allylcysteine; D012645:Selenomethionine; D008715:Methionine; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming); D003545:Cysteine
Drug Metab Dispos. 2002 Oct;30(10):1137-42
12228191
Drug Metab Dispos. 2002 Feb;30(2):119-28
11792679
Aquat Toxicol. 2006 Oct 12;79(4):401-9
16935358
J Biol Chem. 1994 May 13;269(19):14314-22
8188717
Am J Clin Nutr. 2003 May;77(5):1269-77
12716682
Mol Pharmacol. 2006 Jan;69(1):140-53
16214954
Metabolism. 2000 Aug;49(8):1071-7
10954028
Chem Res Toxicol. 1998 Oct;11(10):1145-53
9778310
Food Chem Toxicol. 2006 Mar;44(3):393-7
16181716
Mol Pharmacol. 1993 Mar;43(3):388-96
8450833
Drug Metab Dispos. 2000 Aug;28(8):930-6
10901703
Arch Biochem Biophys. 1994 Jan;308(1):254-7
8311461
J Pharm Pharmacol. 2006 May;58(5):617-23
16640830
Arch Biochem Biophys. 2001 Jul 1;391(1):30-40
11414682
Chem Res Toxicol. 2006 Dec;19(12):1643-9
17173378
Biochem J. 2007 Sep 15;406(3):491-9
17547558
Biochim Biophys Acta. 1993 Mar 5;1162(1-2):127-34
8448176
Mol Pharmacol. 1997 Mar;51(3):507-15
9058607
Drug Metab Dispos. 1996 Aug;24(8):891-8
8869825
Can J Physiol Pharmacol. 1994 Oct;72(10):1238-44
7882190
J Pharmacol Exp Ther. 1992 Jan;260(1):393-401
1731048
J Pharmacol Exp Ther. 2003 Jan;304(1):185-91
12490590
J Clin Invest. 1988 Feb;81(2):390-7
3339126
Pharmacogenetics. 2004 Feb;14(2):117-30
15077013
Pediatr Res. 2002 Feb;51(2):236-43
11809920
Biochem Pharmacol. 1991 Sep 12;42(7):1411-20
1930264
Drug Metab Dispos. 1999 Jan;27(1):46-52
9884308
Mol Pharmacol. 2003 Jan;63(1):253-61
12488558
Pharmacology. 2003 Mar;67(3):113-7
12571405
J Food Sci. 2007 Sep;72(7):S511-5
17995665
J Pharmacol Exp Ther. 2001 Dec;299(3):849-57
11714868
Annu Rev Pharmacol Toxicol. 2006;46:65-100
16402899
Arch Biochem Biophys. 1997 Jun 15;342(2):212-23
9186481
Arch Biochem Biophys. 1984 Aug 15;233(1):50-63
6087744
Drug Metab Dispos. 2000 Sep;28(9):1107-11
10950857
J Biol Chem. 1990 Apr 15;265(11):6139-45
2318851
Eur J Pharm Sci. 2006 May;28(1-2):51-8
16488120
Arch Biochem Biophys. 1996 Sep 1;333(1):109-16
8806760
Arch Biochem Biophys. 1999 Jul 15;367(2):322-32
10395751
Free Radic Res. 2007 Apr;41(4):489-97
17454131